Navigation Links
The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer
Date:9/7/2012

s to advance our clinical development programs and deliver new cancer medicines to patients as efficiently as possible around the world," said Garry Nicholson, president and general manager, Pfizer Oncology. "Non-small cell lung cancer remains a difficult disease to treat despite recent advances, and Pfizer is evaluating dacomitinib in NSCLC across lines of therapy and a range of histologies and molecular subtypes.  By collaborating with SFJ on the continued clinical development of dacomitinib in this patient population, we hope to more immediately bring a new first-line therapy to patients in need."

Dacomitinib is an oral, once-daily, small molecule inhibitor of HER-1 (EGFR), HER-2 and HER-4 tyrosine kinases.  It is being evaluated by Pfizer in a comprehensive clinical development program that includes two global, randomized Phase 3 clinical trials investigating its safety and efficacy as a second-line and refractory treatment for NSCLC.  Dacomitinib has not been approved by any regulatory agency.  

About the SFJ Pharmaceuticals Group
The SFJ Pharmaceuticals Group, which was formed in January of 2009 is a global drug development group of companies, which provides a unique co-development partnering model for some of the world's top pharmaceutical and biotechnology companies.  SFJ uses its financial strength and core team of pharmaceutical development experts to provide highly customized partnering models in which SFJ provides the funding and clinical development supervision, necessary to obtain regulatory approval for some of the most promising drug development programs of Pharmaceutical and Biotechnology companies. SFJ is backed by Abingworth, Clarus and Fintech, which are venture capital firms specializing in bio-pharmaceutical development. Collectively these venture capital firms manage over USD $2.5 billion in funding.

http://www.abingworth.com


'/>"/>
SOURCE SFJ Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
2. Jazz Pharmaceuticals Announces Participation At The 2012 Morgan Stanley Global Healthcare Conference In New York On September 11
3. Cumberland Pharmaceuticals to Present at the UBS Global Life Sciences Conference in New York
4. Actinium Pharmaceuticals Stockholders Vote to Approve Fundraising and Public Listing
5. Global Markets for Membrane Technology for Pharmaceuticals
6. Inovio Pharmaceuticals Takes Major Stride Toward Universal Influenza Vaccine
7. Jazz Pharmaceuticals Enters Definitive Agreement to Sell its Womens Health Business to Meda
8. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
9. Savient Pharmaceuticals to Present at the 6th Annual Imperial Capital Global Opportunities Conference
10. Questcor Pharmaceuticals to Present at Investor Conferences in September
11. Intercept Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Ambit Biosciences Corporation (Nasdaq: ... clinical investigations of quizartinib (AC220), a potent and selective ... of the American Society of Clinical Oncology, held May ... Chicago . Information ... listed below. Abstracts can be viewed online at ...
(Date:5/22/2013)... 22, 2013 /PRNewswire-iReach/ -- MarketReportsOnline.com announces addition of ... Series (4) 2013 Edition Material and Clinical Trial ... Registration: A Guidebook of Registration Application for Imported ... its online database. The traditional medicines ... always regarded by occidental as mysterious medicines. Until ...
(Date:5/22/2013)... May 22, 2013 Assured Pharmacy, Inc. (APHY), ... medications to sufferers of chronic pain, announced it has ... investor relations firm, to raise its visibility and strengthen ... the past year, we have proven our business model ... plans to open two additional new pharmacies in ...
Breaking Medicine Technology:Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 2Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5Assured Pharmacy Hires Hayden IR 2Assured Pharmacy Hires Hayden IR 3
... Dec. 13, 2010 Out of hundreds ... Medicare DualChoice (HMO SNP) is one of only five plans across ... quality and performance from the Centers for Medicare and Medicaid Services ... how well health and drug plans perform on a scale of ...
... 13, 2010 Montefiore Medical Center has introduced a ... reflux disease (GERD), most commonly known as acid reflux. ... not require any incisions, recovery is faster and it ... next step in the evolution of surgery, which can ...
Cached Medicine Technology:IEHP Earns Highest Rating for Medicare Part D Quality and Performance 2Natural Orifice Surgery Introduced to Relieve Acid Reflux 2Natural Orifice Surgery Introduced to Relieve Acid Reflux 3
(Date:5/22/2013)... Garcinia cambogia select is a dual action fat burner ... fat being stored in the body. For a rapid weight ... burner helps people in this regard by making the consumer ... does this by secreting a hormone serotonin which makes people ... emotional overeating. In this way, it keeps a control on ...
(Date:5/22/2013)... Los Angeles, CA (PRWEB) May 22, 2013 ... board, The J. M. Smucker Company, and Danny ... Awards yesterday at the GS1 General Assembly and Global ... Mr. Smucker and Mr. Wegman were recognized for their ... Standards - the most broadly used supply chain standards ...
(Date:5/22/2013)... and teens exposed to radiation during CT scans are ... a large, long-term study. The risks, however, are ... who each had one CT scan, only about six ... years, according to researchers from Australia and Europe. ... to patients when making decisions about CT (computed tomography) ...
(Date:5/22/2013)... German . ... establishing 11 new Research Training Groups to further support ... by the relevant Grants Committee in Bonn. Funding of ... new programmes for an initial period of four and ... Research Training Groups, the Grants Committee approved the extension ...
(Date:5/22/2013)... encouraging a baby to finish the last ounce in their ... the calories soon burn off, a bad habit remains. , ... found that clinical obesity at 24 months of age strongly ... at age two, it puts you on a trajectory where ... adolescence and as an adult," said Forste. "That,s a big ...
Breaking Medicine News(10 mins):Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Overeating learned in infancy, study suggests 2
... difference in effectiveness of 5 drugs currently available , , ... that any one of the five drugs available in ... the others, says an American College of Physicians (ACP) ... just issued a new guideline on drug treatment of ...
... Publishing, an award-winning interactive, visual content developer, today ... the first free, Web-based 3-D interactive model of ... educators, and health and medical professionals, The Visible ... how the human body works. It will also ...
... ANNAPOLIS, Md., March 4 Dozens of ... gathered in Annapolis today as,the General Assembly ... regulations, protections against identity theft, and the ... visited legislators,offices and attended committee hearings on ...
... Market Segments, CHICAGO, March 4 Throw ... Financial services firms, insurers, and,healthcare payors admit they ... to serve baby boomers, who will control some ... who make up the wealthiest generation in history, ...
... CA A nuclear receptor protein, known for controlling ... powerful anti-inflammatory effects in arteries, suppressing atherosclerosis in mice ... research by scientists at the Salk Institute for Biological ... , Their findings, reported in this weeks online edition ...
... swayed by adolescent drug use trends , , TUESDAY, March 4 ... boys are more likely to give up the habit if ... no matter what, new research shows. , The findings ... to the wider world,s embrace of illegal drugs, said study ...
Cached Medicine News:Health News:Groups Issue New Dementia Drug Guidelines 2Health News:Argosy publishing launches The Visible Body 2Health News:Argosy publishing launches The Visible Body 3Health News:Utilities, Long Term Care Bills at Center of 'AARP Day In Annapolis' 2Health News:Diamond's Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers' Health and Wealth Needs 2Health News:Diamond's Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers' Health and Wealth Needs 3Health News:Diamond's Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers' Health and Wealth Needs 4Health News:Diamond's Retirement Study Finds Companies Ill-Prepared to Meet Baby Boomers' Health and Wealth Needs 5Health News:New potential drug target for the treatment of atherosclerosis 2Health News:New potential drug target for the treatment of atherosclerosis 3Health News:Troubled Boys Will Abandon Pot When It's Deemed Uncool 2
... care management tools that support the nursing ... vital signs and I&O information at the ... on-line flow sheets. This design supports compliance ... the hall, or at the nursing station, ...
For superior bar code scanning performance with maximum user comfort at a highly attractive price, the LS 4000i Scanner Series from Symbol Technologies establishes an award-winning standard of excell...
... thermal transfer wristband for printing quality ... that resist smears and abrasion as ... and blood. A time-tested and proven ... management applications. A tamper-evident VOID version ...
... The DataMate Laser Sheeted ... consists of laser-printable sheets ... wristband and laser labels ... The wristbands clear, fold-over ...
Medicine Products: